AI in Pathology Market by Neural Network (GAN, CNN, RNN), Function (Diagnostic, Image Analysis, CDSS, Data Management, Analytics), Use Case (Drug Discovery, Clinical Workflow), End User (Hospital, Labs, Pharma/Biotech), & Region - Global Forecast to 2029

1.1 Study Objectives
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Inclusions & Exclusions
1.3.3 Years Considered
1.3.4 Currency Considered
1.4 Market Stakeholders
1.5 Summary of Changes

2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Study Assumptions
2.5 Research Limitations
2.5.1 Methodology-Related Limitations
2.5.2 Scope-Related Limitations
2.6 Risk Assessment

4.1 AI in Pathology Market Overview
4.2 AI in Pathology Market: Regional Mix
4.3 Asia-Pacific: AI in Pathology Market, by End-user & Country
4.4 Geographic Growth Opportunities

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Development of Cnns and Advanced AI Models
5.2.1.2 Integration of AI into Multiplex Imaging
5.2.1.3 Increasing Cases of Misdiagnoses in Patients
5.2.1.4 Benefits of AI-Augmented Telepathology
5.2.1.5 Advancements in Deep Learning & Image Processing
5.2.2 Restraints
5.2.2.1 High Cost of Digital Pathology Systems
5.2.2.2 Limited AI Expertise and Varied Regulatory Guidelines for Medical Software
5.2.2.3 Inadequate Interoperability Issues with Legacy Systems
5.2.3 Opportunities
5.2.3.1 Increasing Demand for Personalized Medicine
5.2.3.2 Integration of Multi-Omics Data
5.2.3.3 Predictive Analytics for Disease Progression
5.2.4 Challenges
5.2.4.1 Insufficient Data for AI Algorithms
5.2.4.2 Data Privacy & Ethical Concerns
5.2.4.3 Challenges Associated with Interpretability of AI Models
5.3 Trends/Disruptions Impacting Customers’ Businesses
5.4 Industry Trends
5.4.1 Evolution of AI in Pathology
5.5 Ecosystem Analysis
5.6 Value Chain Analysis
5.7 Technology Analysis
5.7.1 Key Technologies
5.7.1.1 Machine Learning and Artificial Intelligence
5.7.1.2 Computer Vision
5.7.2 Complementary Technologies
5.7.2.1 Cloud Computing
5.7.3 Adjacent Technologies
5.7.3.1 Telepathology
5.8 Regulatory Analysis
5.8.1 Regulatory Bodies, Government Agencies, and Other Organizations
5.8.2 Regulatory Landscape
5.8.2.1 North America
5.8.2.1.1 US
5.8.2.1.2 Canada
5.8.2.2 Europe
5.8.2.3 Asia-Pacific
5.8.2.3.1 Japan
5.8.2.3.2 China
5.9 Pricing Analysis
5.9.1 Indicative Pricing Analysis, by Offering
5.9.2 Average Selling Price Trend, by Region
5.10 Porter's Five Forces Analysis
5.10.1 Threat of New Entrants
5.10.2 Threat of Substitutes
5.10.3 Bargaining Power of Suppliers
5.10.4 Bargaining Power of Buyers
5.10.5 Intensity of Competitive Rivalry
5.11 Patent Analysis
5.11.1 Patent Publication Trends for AI in Pathology Solutions
5.11.2 Jurisdiction & Top Applicant Analysis
5.12 Key Stakeholders and Buying Criteria
5.12.1 Key Stakeholders in Buying Process
5.12.2 Buying Criteria
5.13 End-user Analysis
5.13.1 Unmet Needs of End-users
5.13.2 End-user Expectations
5.14 Key Conferences and Events, 2024-2025
5.15 Case Study Analysis
5.15.1 Case Study 1: Pathai Uses Pytorch to Improve Patient Outcomes with AI-Powered Pathology
5.15.2 Case Study 2: Combating Cervical Cancer with AI
5.16 Investment & Funding Scenario
5.17 AI in Pathology Market: Business Models
5.18 Impact of AI/Gen AI on AI in Pathology Market
5.18.1 Key Use Cases
5.18.2 Case Studies of AI/Generative AI Implementation
5.18.2.1 Case Study: Accelerated Biomarker Discovery and Clinical Trial Optimization
5.18.3 Impact of AI/Gen AI on Interconnected and Adjacent Ecosystems
5.18.3.1 Drug Discovery & Development Market
5.18.3.2 Medical Imaging & Diagnostics Market
5.18.4 Users Readiness and Impact Assessment
5.18.4.1 User Readiness
5.18.4.1.1 Pharmaceutical Companies
5.18.4.1.2 Biopharmaceutical Companies
5.18.4.2 Impact Assessment
5.18.4.2.1 User A: Pharmaceutical Companies
5.18.4.2.1.1 Implementation
5.18.4.2.1.2 Impact
5.18.4.2.2 User B: Biopharmaceutical Companies
5.18.4.2.2.1 Implementation
5.18.4.2.2.2 Impact
5.19 Trade Analysis
5.19.1 Import Data
5.19.2 Export Data

6.1 Introduction
6.2 End-To-End Solutions
6.2.1 Increasing Demand for Integrated Workflows in Healthcare Models to Drive Market
6.3 Niche Point Solutions
6.3.1 Growing Focus on Precision Medicine and Targeted Therapy Research to Propel Market
6.4 Technology
6.4.1 Rising Need for Advanced Data Management Solutions to Fuel Uptake
6.5 Hardware
6.6 Microscopes
6.6.1 Automated Analysis of Tissue Samples for Effective Conclusions to Fuel Uptake
6.7 Scanners
6.7.1 Improvements in Image Quality and Precision Diagnostics to Boost Demand
6.8 Storage Systems
6.8.1 Ability to Provide Structured Models of High-Resolution Images to Support Market Growth

7.1 Introduction
7.2 Convolutional Neural Networks (Cnns)
7.2.1 Ability to Provide High-Quality Image Recognition and Objection Detection to Propel Market
7.3 Generative Adversarial Networks (Gans)
7.3.1 Designed for Generation of Accurate Synthetic Pathology Images to Drive Market
7.4 Recurrent Neural Networks (Rnns)
7.4.1 Analysis of Sequential Data and Time-Dependent Patterns to Fuel Uptake
7.5 Other Neural Networks

8.1 Introduction
8.2 Image Analysis
8.2.1 Detection of Cellular Anomalies and Disease Markers to Fuel Uptake
8.3 Diagnostics
8.3.1 Rapid Procession of Automated Samples to Drive Market
8.4 Workflow Management
8.4.1 Optimization of Lab Resources for High-Throughput Results to Fuel Uptake
8.5 Data Management
8.5.1 Advancements in Data Integration & Processing to Boost Demand
8.6 Predictive Analytics
8.6.1 Growing Focus on Early Disease Diagnosis to Drive Market
8.7 Cdss
8.7.1 Provision of Real-Time Insights to Fuel Market
8.8 Automated Report Generation
8.8.1 Increasing Demand for Quality Control to Drive Market
8.9 Quality Assurance Tools
8.9.1 Rising Regulatory Demands to Accelerate Demand for Quality Assurance Tools

9.1 Introduction
9.2 Drug Discovery
9.2.1 Target Identification & Selection
9.2.1.1 Analysis of Molecular & Histological Data for Biomarker Discovery to Fuel Market
9.2.2 Target Validation
9.2.2.1 Increasing Demand for Precision Medicine to Drive Market
9.2.3 Hit Identification & Prioritization
9.2.3.1 Growing Requirement for Rapid Analysis and Cost Efficiency to Fuel Uptake
9.2.4 Hit-To-Lead Identification
9.2.4.1 Advancements in ML to Support Market Growth
9.2.5 Lead Optimization
9.2.5.1 Growing Focus on Therapeutic Efficacy to Propel Market
9.2.6 Candidate Selection & Validation
9.2.6.1 Critical Requirement for Regulatory Approvals to Drive Market
9.3 Disease Diagnosis & Prognosis
9.3.1 Increasing Incidence of Chronic Diseases to Fuel Market
9.4 Clinical Workflow
9.4.1 Structured Automation of Extensive Volume Data to Drive Market
9.5 Training & Education
9.5.1 Utilization of Digital Pathology Systems in Academic Institutes to Support Market Growth

10.1 Introduction
10.2 Pharmaceutical & Biopharmaceutical Companies
10.2.1 Growing Focus on Toxicology Testing to Propel Market
10.3 Hospitals & Reference Laboratories
10.3.1 Increasing Uptake of Infectious Disease Diagnosis to Drive Market
10.4 Academic & Research Institutes
10.4.1 Increasing Investments in Life Sciences Research to Support Market Growth

11.1 Introduction
11.2 North America
11.2.1 Macroeconomic Outlook for North America
11.2.2 US
11.2.2.1 High Healthcare Expenditure and Improvements in Cloud Computing Platforms to Propel Market
11.2.3 Canada
11.2.3.1 Increasing Adoption of Deep Learning for Advanced Healthcare Diagnostics to Drive Market
11.3 Europe
11.3.1 Macroeconomic Outlook for Europe
11.3.2 UK
11.3.2.1 Increasing Focus on Drug Discovery & Development to Boost Demand
11.3.3 Germany
11.3.3.1 Availability of Funding for AI Initiatives to Fuel Uptake
11.3.4 France
11.3.4.1 Increasing Adoption of Big Data in Healthcare Computing to Fuel Uptake
11.3.5 Italy
11.3.5.1 Digital Transformation and Innovation in Healthcare to Support Market Growth
11.3.6 Spain
11.3.6.1 Workforce Shortages to Fuel Market
11.3.7 Rest of Europe
11.4 Asia-Pacific
11.4.1 Macroeconomic Outlook for Asia-Pacific
11.4.2 China
11.4.2.1 Increasing Incidence of Infectious & Chronic Diseases to Fuel Uptake
11.4.3 Japan
11.4.3.1 Advanced Healthcare Infrastructure to Propel Market
11.4.4 India
11.4.4.1 Growing Focus on Healthcare Digitization to Boost Demand
11.4.5 Rest of Asia-Pacific
11.5 Latin America
11.5.1 Macroeconomic Outlook for Latin America
11.5.2 Brazil
11.5.2.1 Strategic Investments for AI Adoption to Support Market Growth
11.5.3 Mexico
11.5.3.1 Growth in Pharmaceutical R&D to Drive Market
11.5.4 Rest of Latin America
11.6 Middle East & Africa
11.6.1 Macroeconomic Outlook for Middle East & Africa
11.6.2 GCC Countries
11.6.2.1 Increasing Investments in Expansion of Technological Expertise to Support Market Growth
11.6.3 Rest of Middle East & Africa

12.1 Introduction
12.2 Key Player Strategies/Right to Win
12.2.1 Overview of Strategies Adopted by Players in AI in Pathology Market
12.3 Revenue Analysis, 2019-2023
12.4 Market Share Analysis, 2023
12.5 Company Evaluation Matrix: Key Players, 2023
12.5.1 Stars
12.5.2 Emerging Leaders
12.5.3 Pervasive Players
12.5.4 Participants
12.5.5 Company Footprint: Key Players, 2023
12.5.5.1 Company Footprint
12.5.5.2 Offering Footprint
12.5.5.3 Use-Case Footprint
12.5.5.4 End-user Footprint
12.5.5.5 Region Footprint
12.6 Company Evaluation Matrix: Startups /SMEs, 2023
12.6.1 Progressive Companies
12.6.2 Responsive Companies
12.6.3 Dynamic Companies
12.6.4 Starting Blocks
12.6.5 Competitive Benchmarking: Startups/SMEs, 2023
12.7 Company Valuation & Financial Metrics
12.7.1 Company Valuation
12.7.2 Financial Metrics
12.7.3 Brand/Software Comparison Analysis
12.8 Competitive Scenario
12.8.1 Product/Service Launches & Approvals
12.8.2 Deals
12.8.3 Other Developments

13.1 Key Players
13.1.1 Koninklijke Philips N.V.
13.1.1.1 Business Overview
13.1.1.2 Products/Services Offered
13.1.1.3 Analyst's View
13.1.1.3.1 Key Strengths
13.1.1.3.2 Strategic Choices
13.1.1.3.3 Weaknesses & Competitive Threats
13.1.2 F. Hoffmann-La Roche Ltd.
13.1.2.1 Business Overview
13.1.2.2 Products/Services Offered
13.1.2.3 Recent Developments
13.1.2.3.1 Product/Service Launches
13.1.2.3.2 Deals
13.1.2.4 Analyst's View
13.1.2.4.1 Key Strengths
13.1.2.4.2 Strategic Choices
13.1.2.4.3 Weaknesses & Competitive Threats
13.1.3 Hologic, Inc.
13.1.3.1 Business Overview
13.1.3.2 Products/Services Offered
13.1.3.3 Recent Developments
13.1.3.3.1 Product/Service Approvals
13.1.3.4 Analyst's View
13.1.3.4.1 Key Strengths
13.1.3.4.2 Strategic Choices
13.1.3.4.3 Weaknesses & Competitive Threats
13.1.4 Akoya Biosciences, Inc.
13.1.4.1 Business Overview
13.1.4.2 Products/Services Offered
13.1.4.3 Recent Developments
13.1.4.3.1 Deals
13.1.4.4 Analyst's View
13.1.4.4.1 Key Strengths
13.1.4.4.2 Strategic Choices
13.1.4.4.3 Weaknesses & Competitive Threats
13.1.5 Aiforia Technologies PLC
13.1.5.1 Business Overview
13.1.5.2 Products/Services Offered
13.1.5.3 Recent Developments
13.1.5.3.1 Deals
13.1.5.4 Analyst's View
13.1.5.4.1 Key Strengths
13.1.5.4.2 Strategic Choices
13.1.5.4.3 Weaknesses & Competitive Threats
13.1.6 Indica Labs Inc.
13.1.6.1 Business Overview
13.1.6.2 Products/Services Offered
13.1.6.3 Recent Developments
13.1.6.3.1 Product/Service Launches & Approvals
13.1.6.3.2 Deals
13.1.6.3.3 Expansions
13.1.7 Optrascan
13.1.7.1 Business Overview
13.1.7.2 Products/Services Offered
13.1.7.3 Recent Developments
13.1.7.3.1 Other Developments
13.1.8 Ibex Medical Analytics Ltd.
13.1.8.1 Business Overview
13.1.8.2 Products/Services Offered
13.1.8.3 Recent Developments
13.1.8.3.1 Product/Service Launches & Approvals
13.1.8.3.2 Deals
13.1.9 Mindpeak GmbH
13.1.9.1 Business Overview
13.1.9.2 Products/Services Offered
13.1.9.3 Recent Developments
13.1.9.3.1 Product/Service Approvals
13.1.9.3.2 Deals
13.1.9.3.3 Other Developments
13.1.10 Tribun Health
13.1.10.1 Business Overview
13.1.10.2 Products/Services Offered
13.1.10.3 Recent Developments
13.1.10.3.1 Deals
13.1.11 Techcyte, Inc.
13.1.11.1 Business Overview
13.1.11.2 Products/Services Offered
13.1.11.3 Recent Developments
13.1.11.3.1 Product/Service Launches
13.1.11.3.2 Deals
13.1.11.3.3 Other Developments
13.1.12 Deep Bio Inc.
13.1.12.1 Business Overview
13.1.12.2 Products/Services Offered
13.1.12.3 Recent Developments
13.1.12.3.1 Deals
13.1.13 Lumea Inc.
13.1.13.1 Business Overview
13.1.13.2 Products/Services Offered
13.1.13.3 Recent Developments
13.1.13.3.1 Deals
13.1.14 Visiopharm
13.1.14.1 Business Overview
13.1.14.2 Products/Services Offered
13.1.14.2.1 Recent Developments
13.1.14.2.2 Product/Service Launches
13.1.14.2.3 Expansions
13.1.15 Aetherai
13.1.15.1 Business Overview
13.1.15.2 Products/Services Offered
13.1.15.3 Recent Developments
13.1.15.3.1 Deals
13.1.16 Aiosyn
13.1.16.1 Business Overview
13.1.16.2 Product/Services Offered
13.1.16.2.1 Product/Service Launches
13.1.16.3 Recent Developments
13.1.16.3.1 Deals
13.1.16.4 Recent Developments
13.1.16.4.1 Other Developments
13.1.17 Paige AI, Inc.
13.1.17.1 Business Overview
13.1.17.2 Products/Services Offered
13.1.17.3 Recent Developments
13.1.17.3.1 Product/Service Launches & Approvals
13.1.17.3.2 Deals
13.1.17.3.3 Other Developments
13.1.18 Proscia, Inc.
13.1.18.1 Business Overview
13.1.18.2 Products/Services Offered
13.1.18.3 Recent Developments
13.1.18.3.1 Product/Service Launches & Enhancements
13.1.18.3.2 Deals
13.1.18.3.3 Other Developments
13.1.19 Pathai, Inc.
13.1.19.1 Business Overview
13.1.19.2 Products/Services Offered
13.1.19.3 Recent Developments
13.1.19.3.1 Product/Service Launches & Approvals
13.1.19.3.2 Deals
13.1.20 Tempus Labs, Inc.
13.1.20.1 Business Overview
13.1.20.2 Products/Services Offered
13.1.20.3 Recent Developments
13.1.20.3.1 Product/Service Launches
13.2 Other Players
13.2.1 Konfoong Bioinformation Tech Co. Ltd.
13.2.2 Domore Diagnostics As
13.2.3 Verily Life Sciences, LLC
13.2.4 Deeppath
13.2.5 4D Path Inc.

14.1 Discussion Guide
14.2 Knowledgestore: The Subscription Portal
14.3 Customization Options

Table 1 Exchange Rates Utilized for Conversion to USD
Table 2 Study Assumption Analysis
Table 3 Risk Assessment Analysis
Table 4 AI in Pathology Market: Role in Ecosystem
Table 5 Regulatory Bodies, Government Agencies, and Other Organizations
Table 6 US Fda: Medical Device Classification
Table 7 US: Medical Device Regulatory Approval Process
Table 8 Canada: Medical Device Regulatory Approval Process
Table 9 Europe: Classification of Ivd Devices
Table 10 Japan: Medical Device Classification Under Pmda
Table 11 China: Classification of Medical Devices
Table 12 Indicative Pricing Analysis, by Offering
Table 13 AI in Pathology Market: Porter's Five Forces Analysis
Table 14 Influence of Stakeholders on Buying Process of AI in Pathology Products (%)
Table 15 Key Buying Criteria for AI in Pathology Products
Table 16 Unmet Needs for AI in Pathology Market
Table 17 End-user Expectations for AI in Pathology Market
Table 18 AI in Pathology Market: List of Conferences and Events
Table 19 Import Data for HS Code 9011, by Country, 2020-2022 (USD Thousand)
Table 20 Export Data for HS Code 9011, by Country, 2020-2022 (USD Thousand)
Table 21 AI in Pathology Market, by Offering, 2022-2029 (USD Million)
Table 22 AI in Pathology Market for Offering, by Country, 2022-2029 (USD Million)
Table 23 AI in Pathology Market for End-To-End Solutions, by Country, 2022-2029 (USD Million)
Table 24 AI in Pathology Market for Niche-Point Solutions, by Country, 2022-2029 (USD Million)
Table 25 AI in Pathology Market for Technology, by Country, 2022-2029 (USD Million)
Table 26 AI in Pathology Market for Hardware, by Type, 2022-2029 (USD Million)
Table 27 AI in Pathology Market for Hardware, by Country, 2022-2029 (USD Million)
Table 28 AI in Pathology Market for Microscopes, by Country, 2022-2029 (USD Million)
Table 29 AI in Pathology Market for Scanners, by Country, 2022-2029 (USD Million)
Table 30 AI in Pathology Market for Storage Systems, by Country, 2022-2029 (USD Million)
Table 31 AI in Pathology Market, by Neural Networks, 2022-2029 (USD Million)
Table 32 AI in Pathology Market for Convolutional Neural Networks, by Country, 2022-2029 (USD Million)
Table 33 AI in Pathology Market for Generative Adversarial Networks, by Country, 2022-2029 (USD Million)
Table 34 AI in Pathology Market for Recurrent Neural Networks, by Country, 2022-2029 (USD Million)
Table 35 AI in Pathology Market for Other Neural Networks, by Country, 2022-2029 (USD Million)
Table 36 AI in Pathology Market, by Function, 2022-2029 (USD Million)
Table 37 AI in Pathology Market for Image Analysis, by Country, 2022-2029 (USD Million)
Table 38 AI in Pathology Market for Diagnostics, by Country, 2022-2029 (USD Million)
Table 39 AI in Pathology Market for Workflow Management, by Country, 2022-2029 (USD Million)
Table 40 AI in Pathology Market for Data Management, by Country, 2022-2029 (USD Million)
Table 41 AI in Pathology Market for Predictive Analytics, by Country, 2022-2029 (USD Million)
Table 42 AI in Pathology Market for Cdss, by Country, 2022-2029 (USD Million)
Table 43 AI in Pathology Market for Automated Report Generation, by Country, 2022-2029 (USD Million)
Table 44 AI in Pathology Market for Quality Assurance Tools, by Country, 2022-2029 (USD Million)
Table 45 AI in Pathology Market, by Use Case, 2022-2029 (USD Million)
Table 46 Drug Discovery Applications for AI in Pathology
Table 47 AI in Pathology Market for Drug Discovery, by Type, 2022-2029 (USD Million)
Table 48 AI in Pathology Market for Drug Discovery, by Country, 2022-2029 (USD Million)
Table 49 AI in Pathology Market for Target Identification & Selection, by Country, 2022-2029 (USD Million)
Table 50 AI in Pathology Market for Target Validation, by Country, 2022-2029 (USD Million)
Table 51 AI in Pathology Market for Hit Identification & Prioritization, by Country, 2022-2029 (USD Million)
Table 52 AI in Pathology Market for Hit-To-Lead, by Country, 2022-2029 (USD Million)
Table 53 AI in Pathology Market for Lead Optimization, by Country, 2022-2029 (USD Million)
Table 54 AI in Pathology Market for Candidate Selection & Validation, by Country, 2022-2029 (USD Million)
Table 55 AI in Pathology Market for Disease Diagnosis & Prognosis, by Country, 2022-2029 (USD Million)
Table 56 AI in Pathology Market for Clinical Workflow, by Country, 2022-2029 (USD Million)
Table 57 AI in Pathology Market for Training & Education, by Country, 2022-2029 (USD Million)
Table 58 AI in Pathology Market, by End-user, 2022-2029 (USD Million)
Table 59 AI in Pathology Market for Pharmaceutical & Biopharmaceutical Companies, by Country, 2022-2029 (USD Million)
Table 60 AI in Pathology Market for Hospitals & Reference Laboratories, by Country, 2022-2029 (USD Million)
Table 61 AI in Pathology Market for Academic & Research Institutes, by Country, 2022-2029 (USD Million)
Table 62 AI in Pathology Market, by Region, 2022-2029 (USD Million)
Table 63 North America: AI in Pathology Market, by Country, 2022-2029 (USD Million)
Table 64 North America: AI in Pathology Market, by Offering, 2022-2029 (USD Million)
Table 65 North America: AI in Pathology Market, by Function, 2022-2029 (USD Million)
Table 66 North America: AI in Pathology Market, by Neural Network, 2022-2029 (USD Million)
Table 67 North America: AI in Pathology Market, by Use Case, 2022-2029 (USD Million)
Table 68 North America: AI in Pathology Market, by End-user, 2022-2029 (USD Million)
Table 69 US: AI in Pathology Market, by Offering, 2022-2029 (USD Million)
Table 70 US: AI in Pathology Market, by Function, 2022-2029 (USD Million)
Table 71 US: AI in Pathology Market, by Neural Network, 2022-2029 (USD Million)
Table 72 US: AI in Pathology Market, by Use Case, 2022-2029 (USD Million)
Table 73 US: AI in Pathology Market, by End-user, 2022-2029 (USD Million)
Table 74 Canada: AI in Pathology Market, by Offering, 2022-2029 (USD Million)
Table 75 Canada: AI in Pathology Market, by Function, 2022-2029 (USD Million)
Table 76 Canada: AI in Pathology Market, by Neural Network, 2022-2029 (USD Million)
Table 77 Canada: AI in Pathology Market, by Use Case, 2022-2029 (USD Million)
Table 78 Canada: AI in Pathology Market, by End-user, 2022-2029 (USD Million)
Table 79 Europe: AI in Pathology Market, by Country, 2022-2029 (USD Million)
Table 80 Europe: AI in Pathology Market, by Offering, 2022-2029 (USD Million)
Table 81 Europe: AI in Pathology Market, by Function, 2022-2029 (USD Million)
Table 82 Europe: AI in Pathology Market, by Neural Network, 2022-2029 (USD Million)
Table 83 Europe: AI in Pathology Market, by Use Case, 2022-2029 (USD Million)
Table 84 Europe: AI in Pathology Market, by End-user, 2022-2029 (USD Million)
Table 85 UK: AI in Pathology Market, by Offering, 2022-2029 (USD Million)
Table 86 UK: AI in Pathology Market, by Function, 2022-2029 (USD Million)
Table 87 UK: AI in Pathology Market, by Neural Network, 2022-2029 (USD Million)
Table 88 UK: AI in Pathology Market, by Use Case, 2022-2029 (USD Million)
Table 89 UK: AI in Pathology Market, by End-user, 2022-2029 (USD Million)
Table 90 Germany: AI in Pathology Market, by Offering, 2022-2029 (USD Million)
Table 91 Germany: AI in Pathology Market, by Function, 2022-2029 (USD Million)
Table 92 Germany: AI in Pathology Market, by Neural Network, 2022-2029 (USD Million)
Table 93 Germany: AI in Pathology Market, by Use Case, 2022-2029 (USD Million)
Table 94 Germany: AI in Pathology Market, by End-user, 2022-2029 (USD Million)
Table 95 France: AI in Pathology Market, by Offering, 2022-2029 (USD Million)
Table 96 France: AI in Pathology Market, by Function, 2022-2029 (USD Million)
Table 97 France: AI in Pathology Market, by Neural Network, 2022-2029 (USD Million)
Table 98 France: AI in Pathology Market, by Use Case, 2022-2029 (USD Million)
Table 99 France: AI in Pathology Market, by End-user, 2022-2029 (USD Million)
Table 100 Italy: AI in Pathology Market, by Offering, 2022-2029 (USD Million)
Table 101 Italy: AI in Pathology Market, by Function, 2022-2029 (USD Million)
Table 102 Italy: AI in Pathology Market, by Neural Network, 2022-2029 (USD Million)
Table 103 Italy: AI in Pathology Market, by Use Case, 2022-2029 (USD Million)
Table 104 Italy: AI in Pathology Market, by End-user, 2022-2029 (USD Million)
Table 105 Spain: AI in Pathology Market, by Offering, 2022-2029 (USD Million)
Table 106 Spain: AI in Pathology Market, by Function, 2022-2029 (USD Million)
Table 107 Spain: AI in Pathology Market, by Neural Network, 2022-2029 (USD Million)
Table 108 Spain: AI in Pathology Market, by Use Case, 2022-2029 (USD Million)
Table 109 Spain: AI in Pathology Market, by End-user, 2022-2029 (USD Million)
Table 110 Rest of Europe: AI in Pathology Market, by Offering, 2022-2029 (USD Million)
Table 111 Rest of Europe: AI in Pathology Market, by Function, 2022-2029 (USD Million)
Table 112 Rest of Europe: AI in Pathology Market, by Neural Network, 2022-2029 (USD Million)
Table 113 Rest of Europe: AI in Pathology Market, by Use Case, 2022-2029 (USD Million)
Table 114 Rest of Europe: AI in Pathology Market, by End-user, 2022-2029 (USD Million)
Table 115 Asia-Pacific: AI in Pathology Market, by Country, 2022-2029 (USD Million)
Table 116 Asia-Pacific: AI in Pathology Market, by Offering, 2022-2029 (USD Million)
Table 117 Asia-Pacific: AI in Pathology Market, by Function, 2022-2029 (USD Million)
Table 118 Asia-Pacific: AI in Pathology Market, by Neural Network, 2022-2029 (USD Million)
Table 119 Asia-Pacific: AI in Pathology Market, by Use Case, 2022-2029 (USD Million)
Table 120 Asia-Pacific: AI in Pathology Market, by End-user, 2022-2029 (USD Million)
Table 121 China: AI in Pathology Market, by Offering, 2022-2029 (USD Million)
Table 122 China: AI in Pathology Market, by Function, 2022-2029 (USD Million)
Table 123 China: AI in Pathology Market, by Neural Network, 2022-2029 (USD Million)
Table 124 China: AI in Pathology Market, by Use Case, 2022-2029 (USD Million)
Table 125 China: AI in Pathology Market, by End-user, 2022-2029 (USD Million)
Table 126 Japan: Cancer Incidence, by Cancer Type, 2020 vs. 2040
Table 127 Japan: AI in Pathology Market, by Offering, 2022-2029 (USD Million)
Table 128 Japan: AI in Pathology Market, by Function, 2022-2029 (USD Million)
Table 129 Japan: AI in Pathology Market, by Neural Network, 2022-2029 (USD Million)
Table 130 Japan: AI in Pathology Market, by Use Case, 2022-2029 (USD Million)
Table 131 Japan: AI in Pathology Market, by End-user, 2022-2029 (USD Million)
Table 132 India: AI in Pathology Market, by Offering, 2022-2029 (USD Million)
Table 133 India: AI in Pathology Market, by Function, 2022-2029 (USD Million)
Table 134 India: AI in Pathology Market, by Neural Network, 2022-2029 (USD Million)
Table 135 India: AI in Pathology Market, by Use Case, 2022-2029 (USD Million)
Table 136 India: AI in Pathology Market, by End-user, 2022-2029 (USD Million)
Table 137 Rest of Asia-Pacific: AI in Pathology Market, by Offering, 2022-2029 (USD Million)
Table 138 Rest of Asia-Pacific: AI in Pathology Market, by Function, 2022-2029 (USD Million)
Table 139 Rest of Asia-Pacific: AI in Pathology Market, by Neural Network, 2022-2029 (USD Million)
Table 140 Rest of Asia-Pacific: AI in Pathology Market, by Use Case, 2022-2029 (USD Million)
Table 141 Rest of Asia-Pacific: AI in Pathology Market, by End-user, 2022-2029 (USD Million)
Table 142 Latin America: AI in Pathology Market, by Country, 2022-2029 (USD Million)
Table 143 Latin America: AI in Pathology Market, by Offering, 2022-2029 (USD Million)
Table 144 Latin America: AI in Pathology Market, by Function, 2022-2029 (USD Million)
Table 145 Latin America: AI in Pathology Market, by Neural Network, 2022-2029 (USD Million)
Table 146 Latin America: AI in Pathology Market, by Use Case, 2022-2029 (USD Million)
Table 147 Latin America: AI in Pathology Market, by End-user, 2022-2029 (USD Million)
Table 148 Brazil: AI in Pathology Market, by Offering, 2022-2029 (USD Million)
Table 149 Brazil: AI in Pathology Market, by Function, 2022-2029 (USD Million)
Table 150 Brazil: AI in Pathology Market, by Neural Network, 2022-2029 (USD Million)
Table 151 Brazil: AI in Pathology Market, by Use Case, 2022-2029 (USD Million)
Table 152 Brazil: AI in Pathology Market, by End-user, 2022-2029 (USD Million)
Table 153 Mexico: AI in Pathology Market, by Offering, 2022-2029 (USD Million)
Table 154 Mexico: AI in Pathology Market, by Function, 2022-2029 (USD Million)
Table 155 Mexico: AI in Pathology Market, by Neural Network, 2022-2029 (USD Million)
Table 156 Mexico: AI in Pathology Market, by Use Case, 2022-2029 (USD Million)
Table 157 Mexico: AI in Pathology Market, by End-user, 2022-2029 (USD Million)
Table 158 Rest of Latin America: AI in Pathology Market, by Offering, 2022-2029 (USD Million)
Table 159 Rest of Latin America: AI in Pathology Market, by Function, 2022-2029 (USD Million)
Table 160 Rest of Latin America: AI in Pathology Market, by Neural Network, 2022-2029 (USD Million)
Table 161 Rest of Latin America: AI in Pathology Market, by Use Case, 2022-2029 (USD Million)
Table 162 Rest of Latin America: AI in Pathology Market, by End-user, 2022-2029 (USD Million)
Table 163 Middle East & Africa: AI in Pathology Market, by Region, 2022-2029 (USD Million)
Table 164 Middle East & Africa: AI in Pathology Market, by Offering, 2022-2029 (USD Million)
Table 165 Middle East & Africa: AI in Pathology Market, by Function, 2022-2029 (USD Million)
Table 166 Middle East & Africa: AI in Pathology Market, by Neural Network, 2022-2029 (USD Million)
Table 167 Middle East & Africa: AI in Pathology Market, by Use Case, 2022-2029 (USD Million)
Table 168 Middle East & Africa: AI in Pathology Market, by End-user, 2022-2029 (USD Million)
Table 169 GCC Countries: AI in Pathology Market, by Offering, 2022-2029 (USD Million)
Table 170 GCC Countries: AI in Pathology Market, by Function, 2022-2029 (USD Million)
Table 171 GCC Countries: AI in Pathology Market, by Neural Network, 2022-2029 (USD Million)
Table 172 GCC Countries: AI in Pathology Market, by Use Case, 2022-2029 (USD Million)
Table 173 GCC Countries: AI in Pathology Market, by End-user, 2022-2029 (USD Million)
Table 174 Rest of Middle East & Africa: AI in Pathology Market, by Offering, 2022-2029 (USD Million)
Table 175 Rest of Middle East & Africa: AI in Pathology Market, by Function, 2022-2029 (USD Million)
Table 176 Rest of Middle East & Africa: AI in Pathology Market, by Neural Network, 2022-2029 (USD Million)
Table 177 Rest of Middle East & Africa: AI in Pathology Market, by Use Case, 2022-2029 (USD Million)
Table 178 Rest of Middle East & Africa: AI in Pathology Market, by End-user, 2022-2029 (USD Million)
Table 179 Overview of Strategies Deployed by Key Companies
Table 180 AI in Pathology Market: Degree of Competition
Table 181 Offering Footprint Analysis
Table 182 Use-Case Footprint Analysis
Table 183 End-user Footprint Analysis
Table 184 Region Footprint Analysis
Table 185 AI in Pathology Market: Detailed List of Key Start-Ups/SMEs
Table 186 AI in Pathology Market: Competitive Benchmarking of Key Emerging Players/Startups
Table 187 AI in Pathology Market: Product/Service Launches & Approvals, January 2021-October 2024
Table 188 AI in Pathology Market: Deals, January 2021-October 2024
Table 189 AI in Pathology Market: Other Developments, 2021-2024
Table 190 Koninklijke Philips N.V.: Company Overview
Table 191 Koninklijke Philips N.V.: Products/Services Offered
Table 192 F. Hoffmann-La Roche Ltd.: Company Overview
Table 193 F. Hoffmann La Roche Ltd.: Products/Services Offered
Table 194 F. Hoffmann-La Roche Ltd.: Product/Service Launches, January 2021-October 2024
Table 195 F. Hoffmann-La Roche Ltd.: Deals, January 2021-October 2024
Table 196 Hologic, Inc.: Company Overview
Table 197 Hologic, Inc.: Products/Services Offered
Table 198 Hologic, Inc.: Product/Service Approvals, January 2021-October 2024
Table 199 Akoya Biosciences, Inc.: Company Overview
Table 200 Akoya Biosciences, Inc.: Product/Services Offered
Table 201 Akoya Biosciences Inc.: Deals, January 2021-October 2024
Table 202 Aiforia Technologies PLC: Company Overview
Table 203 Aiforia Technologies PLC: Product/Services Offered
Table 204 Aiforia Technologies PLC: Deals, January 2021-October 2024
Table 205 Indica Labs Inc.: Company Overview
Table 206 Indica Labs Inc.: Products/Services Offered
Table 207 Indica Labs Inc.: Product/Service Launches & Approvals, January 2021-October 2024
Table 208 Indica Labs Inc.: Deals, January 2021-October 2024
Table 209 Indica Labs Inc.: Expansions, January 2021-October 2024
Table 210 Optrascan: Company Overview
Table 211 Optrascan: Products/Services Offered
Table 212 Optrascan: Other Developments, January 2021-October 2024
Table 213 Ibex Medical Analytics Ltd.: Company Overview
Table 214 Ibex Medical Analytics Ltd.: Products/Services Offered
Table 215 Ibex Medical Analytics Ltd.: Product/Service Launches/Approvals, January 2021-October 2024
Table 216 Ibex Medical Analytics Ltd.: Deals, January 2021-October 2024
Table 217 Mindpeak GmbH: Company Overview
Table 218 Mindpeak GmbH: Products/Services Offered
Table 219 Mindpeak GmbH: Product/Service Approvals, January 2021-October 2024
Table 220 Mindpeak GmbH: Deals, January 2021-October 2024
Table 221 Mindpeak GmbH: Other Developments, January 2021-October 2024
Table 222 Tribun Health: Company Overview
Table 223 Tribun Health: Products/Services Offered
Table 224 Tribun Health: Deals, January 2021-October 2024
Table 225 Techcyte, Inc.: Company Overview
Table 226 Techcyte, Inc.: Products/Services Offered
Table 227 Techcyte, Inc.: Product/Service Launches, January 2021-October 2024
Table 228 Techcyte, Inc.: Deals, January 2021-October 2024
Table 229 Techcyte, Inc.: Other Developments, January 2021-October 2024
Table 230 Deep Bio Inc.: Company Overview
Table 231 Deep Bio Inc.: Products/Services Offered
Table 232 Deep Bio Inc.: Deals, January 2021-October 2024
Table 233 Lumea Inc.: Company Overview
Table 234 Lumea Inc.: Products/Services Offered
Table 235 Lumea Inc.: Deals, January 2021-October 2024
Table 236 Visiopharm: Company Overview
Table 237 Visiopharm: Products/Services Offered
Table 238 Visiopharm: Product Launches, January 2021-October 2024
Table 239 Visiopharm: Expansions, January 2021-October 2024
Table 240 Aetherai: Company Overview
Table 241 Aetherai: Products/Services Offered
Table 242 Aetherai: Deals, January 2021-October 2024
Table 243 Aiosyn: Company Overview
Table 244 Aiosyn: Products/Services Offered
Table 245 Aiosyn: Product/Service Launches, January 2021-October 2024
Table 246 Aiosyn: Deals, January 2021-October 2024
Table 247 Aiosyn: Other Developments, January 2021-October 2024
Table 248 Paige AI, Inc.: Company Overview
Table 249 Paige AI, Inc.: Products/Services Offered
Table 250 Paige AI, Inc.: Product/Service Launches & Approvals, January 2021-October 2024
Table 251 Paige AI, Inc.: Deals, January 2021-October 2024
Table 252 Paige AI, Inc.: Other Developments, January 2021-October 2024
Table 253 Proscia, Inc.: Company Overview
Table 254 Proscia, Inc.: Products/Services Offered
Table 255 Proscia, Inc.: Product/Service Launches & Enhancements, January 2021-October 2024
Table 256 Proscia, Inc.: Deals, January 2021-October 2024
Table 257 Proscia, Inc.: Other Developments, January 2021-October 2024
Table 258 Pathai, Inc.: Company Overview
Table 259 Pathai, Inc.: Products/Services Offered
Table 260 Pathai, Inc.: Product/Service Launches & Approvals, January 2021-October 2024
Table 261 Pathai, Inc.: Deals, January 2021-October 2024
Table 262 Tempus Labs, Inc.: Company Overview
Table 263 Tempus Labs, Inc.: Products/Services Offered
Table 264 Tempus Labs, Inc.: Product/Service Launches, January 2021-October 2024
Table 265 Konfoong Bioinformation Tech Co. Ltd.: Company Overview
Table 266 Domore Diagnostics As: Company Overview
Table 267 Verily Life Sciences, LLC: Company Overview
Table 268 Deeppath: Company Overview
Table 269 4D Path Inc.: Company Overview

Figure 1 Research Design
Figure 2 Primary Sources
Figure 3 Breakdown of Primary Interviews (Supply Side): by Company Type, Designation, and Region
Figure 4 Market Size Estimation: Revenue Share Analysis
Figure 5 AI in Pathology Market: Revenue Share Analysis Illustration
Figure 6 Bottom-Up Approach: End-user Spending on AI in Pathology
Figure 7 AI in Pathology Market: CAGR Projections from Analysis of Drivers, Restraints, Opportunities, and Challenges (2024-2029)
Figure 8 CAGR Projections: Supply-Side Analysis
Figure 9 Top-Down Approach
Figure 10 Data Triangulation Methodology
Figure 11 AI in Pathology Market, by Offering, 2024 vs. 2029 (USD Million)
Figure 12 AI in Pathology Market, by Neural Network, 2024 vs. 2029 (USD Million)
Figure 13 AI in Pathology Market, by Use Case, 2024 vs. 2029 (USD Million)
Figure 14 AI in Pathology Market, by End-user, 2024 vs. 2029 (USD Million)
Figure 15 AI in Pathology Market: Geographic Snapshot
Figure 16 Development of Cnns and AI Learning Models to Propel Market
Figure 17 North America to Dominate Market During Forecast Period
Figure 18 Pharmaceutical & Biopharmaceutical Companies in China Accounted for Largest Market Share in 2023
Figure 19 US to Register Highest Growth Rate During Forecast Period
Figure 20 AI in Pathology Market: Drivers, Restraints, Opportunities, and Challenges
Figure 21 Healthcare Breaches Reported to US Department of Health and Human Services (September 2024)
Figure 22 AI in Pathology Market: Trends/Disruptions Impacting Customers’ Businesses
Figure 23 Ecosystem Analysis
Figure 24 Value Chain Analysis
Figure 25 Europe: Ivdr Timeline
Figure 26 There is Moderate-To-High Competitive Intensity Among Market Players
Figure 27 Number of Patents Published, January 2015-October 2024
Figure 28 Top Applicants & Owners (Companies/Institutions) for AI in Pathology Patents (January 2015 to May 2024)
Figure 29 Influence of Stakeholders on Buying Process of AI in Pathology Products
Figure 30 Key Buying Criteria for AI in Pathology Products
Figure 31 Funding Activities in AI in Pathology Market
Figure 32 Market Potential of AI/Generative AI in Pathology
Figure 33 North America: AI in Pathology Market Snapshot
Figure 34 Asia-Pacific: AI in Pathology Market Snapshot
Figure 35 Revenue Analysis of Key Players for AI in Pathology Market, 2019-2023
Figure 36 AI in Pathology Market: Market Share Analysis (2023)
Figure 37 AI in Pathology Market: Company Evaluation Matrix (Key Players), 2023
Figure 38 AI in Pathology Market: Company Footprint
Figure 39 AI in Pathology Market: Company Evaluation Matrix (Startups/SMEs), 2023
Figure 40 Year-To-Date (Ytd) Price Total Return and 5-Year Stock Beta of Life Science Analytics Vendors
Figure 41 EV/Ebitda of Key Vendors
Figure 42 AI in Pathology Market: Brand/Product Comparison Analysis
Figure 43 Koninklijke Philips N.V.: Company Snapshot (2023)
Figure 44 F. Hoffmann-La Roche Ltd.: Company Snapshot (2023)
Figure 45 Hologic, Inc.: Company Snapshot (2023)
Figure 46 Akoya Biosciences, Inc.: Company Snapshot (2023)
Figure 47 Aiforia Technologies PLC: Company Snapshot (2023)